tiprankstipranks
Trending News
More News >

MedX Health Expands Teledermatology Services in Italy Through Strategic Partnership

Story Highlights
MedX Health Expands Teledermatology Services in Italy Through Strategic Partnership

Confident Investing Starts Here:

MedX Health ( (TSE:MDX) ) has issued an update.

MedX Health Corp. has announced a strategic partnership with Vitamed Biomedical and Medispa to expand its teledermatology services in Italy. This collaboration will deploy MedX’s SIAscope on DermSecure platform across Medispa’s network, enhancing access to advanced skin screening and preventive care. The initiative is part of MedX’s international growth strategy, aiming to improve early melanoma detection through non-invasive methods. Italy is a significant growth market for MedX, with increasing demand for accessible dermatological screening due to heightened awareness of skin cancer risks.

More about MedX Health

MedX Health Corp., based in Ontario, Canada, is a prominent developer of non-invasive skin analysis and teledermatology solutions. The company’s SIAscopy technology, part of the DermSecure platform, allows for pain-free imaging of skin lesions for swift remote dermatologist evaluation. MedX’s products are approved for use in several markets, including Canada, the United States, Europe, and Australia.

Average Trading Volume: 105,107

Technical Sentiment Signal: Buy

Current Market Cap: C$20.01M

For a thorough assessment of MDX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1